SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001140361-24-028932
Filing Date
2024-06-05
Accepted
2024-06-05 06:43:23
Documents
15

Document Format Files

Seq Description Document Type Size
1 F-1/A ny20018048x10_f1a.htm F-1/A 6997320
2 EXHIBIT 4.1 ny20018048x10_ex4-1.htm EX-4.1 344267
3 EXHIBIT 5.1 ny20018048x10_ex5-1.htm EX-5.1 36185
4 EXHIBIT 10.10 ny20018048x10_ex10-10.htm EX-10.10 237520
5 EXHIBIT 23.1 ny20018048x10_ex23-1.htm EX-23.1 2326
6 FILING FEES TABLE ny20018048x10_ex107.htm EX-FILING FEES 38709
7 logo_telix.jpg GRAPHIC 36490
8 ny20018048x10_ex4-1image01.jpg GRAPHIC 165446
9 ny20018048x10_ex4-1image02.jpg GRAPHIC 6443
10 ny20018048x10_ex5-1image01.jpg GRAPHIC 48542
11 ny20018048x10_ex5-1image02.jpg GRAPHIC 38747
12 ny20018048x10_ex10-10image01.jpg GRAPHIC 1828
13 ny20018048x10_ex10-10image02.jpg GRAPHIC 4466
14 ny20018048x10_ex10-10image03.jpg GRAPHIC 14282
15 ny20018048x10_graphic01.jpg GRAPHIC 436176
  Complete submission text file 0001140361-24-028932.txt   8694325
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-279471 | Film No.: 241020676
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)